Compelling evidence indicates that Nogo-A signaling is involved in neuronal dysfunction and repair mechanisms in different neurodegenerative conditions, including spinal cord injury, ALS, Alzheimer’s and stroke [20,21,22,23] as well as psychiatric disorders such as schizophrenia [24]. This evidence concerns the gene RTN4 and stroke disorder.